我要投票 羚锐在中草药行业中的票数:93
· 外 推 电 报 ·
2025-02-05 21:00:37 星期三

【羚锐是哪个国家的品牌?】

羚锐是什么牌子?「羚锐」是 河南羚锐制药股份有限公司 旗下著名品牌。该品牌发源于河南,由创始人熊伟在1999-04-18期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

河南羚锐制药股份有限公司始创于1992年6月,由河南省信阳羚羊山制药厂和香港锐星企业公司合资组建而成,2000年10月成功上市,成长为国内知名制药企业。目前,公司在北京、上海、武汉、郑州、信阳等地控股、参股十余家企业,拥有多个科研、生产基地,其中羚锐新县生态工业园为国内最大的橡胶膏剂药品生产基地,羚锐信阳科技园为国内先进的大型口服药生产基地,建立在北京的羚锐药物研究院和羚锐伟业科技有限公司为公司的科技研发基地。公司资产总额10亿元,年创利税逾亿元,已成为当地经济发展的支柱企业。

公司拥有橡胶膏剂、片剂、胶囊剂、颗粒剂、酊剂等十大剂型百余种产品,其中包括通络祛痛膏(骨质增生一贴灵)、培元通脑胶囊、丹鹿通督片、胃疼宁片、参芪降糖胶囊等独家拥有知识产权的产品及国家中药保护品种和国家医保药品。公司的所有产品剂型及其生产车间均通过国家GMP认证,质量标准实现了与国际接轨。

公司先后被评为“全国中药工业50强企业”、“全国中药系统先进集体”、“全国医药优秀企业”、“国家知识产权试点单位”,1999年和2005年先后两次被中央文明委表彰为“全国精神文明建设工作先进单位”,2001年被国家科技部认定为“国家火炬计划重点高新技术企业”,公司党委被中组部命名表彰为“全国先进基层党组织”;2002年“羚锐”商标被国家工商行政管理总局认定为“中国驰名商标”,成为国内橡胶膏剂药业中首件驰名商标。藉此,羚锐制药被业界誉为“中国橡胶膏剂药业第一品牌”。

浴火淬炼,十数年磨剑,羚锐始崛起,并稳健前进。

以“诚信立业,造福人类”为本,弘“团结、进取、创新、奉献”之志,坚持创新,实施人才兴企战略,以高新技术与传统药理、现代理念与先进文化完美融合,构筑企业平台,共享发展资源,我们将进一步提升核心竞争力,着力打造医药的优秀企业,成就百年基业。

英文翻译:Henan Lingrui Pharmaceutical Co., Ltd. was founded in June 1992 by Henan Xinyang lingyangshan pharmaceutical factory and Hong Kong Ruixing enterprise company. It was successfully listed in October 2000 and grew into a well-known pharmaceutical enterprise in China. At present, the company holds and shares more than ten enterprises in Beijing, Shanghai, Wuhan, Zhengzhou, Xinyang and other places, and has many scientific research and production bases. Among them, Lingrui new County Ecological Industrial Park is the largest rubber paste drug production base in China, Lingrui Xinyang science and technology park is the advanced large oral drug production base in China, and Lingrui Drug Research Institute and Lingrui Weiye science and technology established in Beijing Ltd. is the R & D base of the company. The company has a total assets of 1 billion yuan and an annual income tax of more than 100 million yuan, which has become a pillar enterprise of local economic development. The company has more than 100 kinds of products in ten dosage forms including rubber plaster, tablet, capsule, granule and tincture, including Tongluo Qutong plaster (hyperosteogeny Yitieling), Peiyuan Tongnao capsule, Danlu Tongdu tablet, Weitongning tablet, Shenqi Jiangtang Capsule and other products with exclusive intellectual property rights, national traditional Chinese medicine protection varieties and national medical insurance drugs. All the dosage forms and production workshops of the company have passed the national GMP certification, and the quality standards have been in line with the international standards. The company has been awarded as "top 50 enterprises of Chinese medicine industry", "advanced collective of Chinese medicine system", "excellent enterprise of Chinese medicine" and "pilot unit of national intellectual property". In 1999 and 2005, the company was awarded as "advanced unit of national spiritual civilization construction" by the central civilization Committee. In 2001, the company was recognized as "key high and new technology of national Torch Plan" by the Ministry of science and technology In 2002, "Lingrui" trademark was recognized as "China's well-known trademark" by the State Administration for Industry and commerce, and became the first well-known trademark in the domestic rubber paste pharmaceutical industry. Therefore, Lingrui pharmaceutical is known as "the first brand of Chinese rubber paste pharmaceutical industry". Bath fire quenching, more than ten years of sword sharpening, antelope sharp began to rise, and steady progress. Based on the principle of "building a business in good faith and benefiting mankind", we will carry out the strategy of "uniting, enterprising, innovating and dedicating", persist in innovation, carry out the strategy of developing an enterprise with talents, perfectly integrate high and new technology with traditional pharmacology, modern concept and advanced culture, build an enterprise platform and share development resources. We will further enhance our core competitiveness and strive to build an excellent enterprise in medicine, Achieve a century long foundation.

本文链接: https://www.waitui.com/brand/e8963bc9e.html 联系电话:03762973599

千城特选小程序码

7×24h 快讯

房地产融资协调机制工作专班有关负责人:目前万科房地产项目建设正在平稳有序推进中

房地产融资协调机制工作专班有关负责人表示,从专班掌握的情况看,2024年,万科交付住房超过18万套,全面完成保交房目标任务。从各地城市房地产融资协调机制工作专班了解的情况看,目前万科房地产项目建设正在平稳有序推进中,“白名单”制度将提供有力的融资支持,充分保障项目建设交付。(中国建设报)

2小时前

迪士尼第一财季营收247亿美元,同比增长5%

2月5日,华特迪士尼公司发布截至2024年12月28日的2025财年第一季度业绩:营收为247亿美元,同比增长5%;摊薄后每股收益为1.40美元,同比增长35%。(界面)

2小时前

李强:锚定发展目标因时因势加大逆周期调节力度,聚焦突出问题整合资源集中发力

国务院总理李强2月5日主持召开国务院第七次全体会议。李强指出,要系统化创造性地抓好落实。既要注重整体把握,综合平衡好国内和国外、当前和长远、宏观和微观、发展和安全等关系,在多重目标中找到有效路径,也要寻求突破突围,找准潜力足、空间大的发展领域,谋划好牵引性强、撬动性强的工作抓手,打造更多能够带动全局的突出亮点。要认真总结和丰富拓展工作中探索的好做法,锚定发展目标因时因势加大逆周期调节力度,聚焦突出问题整合资源集中发力,敢于打破常规推出可感可及的政策举措,及时回应关切加强政策与市场的互动。(新华社)

2小时前

李强:采取有力举措在做强国内大循环、推动科技创新、促进产业升级等重点领域实现新突破

国务院总理李强2月5日主持召开国务院第七次全体会议。李强强调,要以更加强烈的担当、更加积极的作为推动高质量发展取得新成效。要坚定信心、知难共进,客观辩证看待外部形势变化,统筹解决国内经济问题和应对外部挑战,变压力为动力,采取有力举措在做强国内大循环、推动科技创新、促进产业升级等重点领域实现新突破,并着眼长远打造我国发展新优势。(新华社)

2小时前

杭钢股份:公司与DeepSeek系统的开发、应用等核心技术无关

36氪获悉,杭钢股份公告,公司关注到媒体有关于子公司DeepSeek部署适配的相关报道,公司主营业务为钢铁及其压延产品的生产和销售。钢铁及相关业务营业收入占比超过总额的90%。短期内,公司主营业务不会发生变化。相关媒体报道中涉及的DeepSeek部署适配是指,在上述业务模式下,公司在合作伙伴的系统中安装DeepSeek软件,安装后将算力设备对外提供租赁服务。公司与DeepSeek系统的开发、应用等核心技术无关,且与杭州深度求索人工智能基础技术研究有限公司无任何业务往来。

2小时前

本页详细列出关于前列康的品牌信息,含品牌所属公司介绍,前列康所处行业的品牌地位及优势。
咨询